Review

Accepted on 22 Oct 2024

Alcohol-related Liver Disease (ALD): Current perspectives on pathogenesis, therapeutic strategies, and animal models

in Gastrointestinal and Hepatic Pharmacology

Xiao Hong
Shuo Huang
He Jiang
Qing Ma
Qihan Luo
Jiang Qiu
Chunlu Cao
Yufan Chen
Yiyang Xu
Chunfeng Sun

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1432480

Original Research

Published on 22 Oct 2024

GYY4137, as a slow-releasing H2S donor, ameliorates sodium deoxycholate–induced chronic intestinal barrier injury and gut microbiota dysbiosis

in Gastrointestinal and Hepatic Pharmacology

Shaorong Pan
Han Yan
Jing Zhu
Yuanyuan Ma
Pengyuan Wang
Yucun Liu
Zeyang Chen

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1476407

571 views

Systematic Review

Published on 17 Oct 2024

Comparative effectiveness of treatments for recurrent Clostridioides difficile infection: a network meta-analysis of randomized controlled trials

in Gastrointestinal and Hepatic Pharmacology

Hong Duo
Yanwei Yang
Guqing Zhang
Yingxin Chen
Yumeng Cao
Linjie Luo
Huaqin Pan
Qifa Ye

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1430724

699 views

Review

Published on 16 Oct 2024

Retinoid X receptor heterodimers in hepatic function: structural insights and therapeutic potential

in Gastrointestinal and Hepatic Pharmacology

Renjie Xu
Linyue Zhang
Hao Pan
Yong Zhang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1464655

543 views

Original Research

Published on 16 Oct 2024

Effectiveness of biologic therapies in achieving treatment targets in inflammatory bowel disease; real-world data from the Middle East (ENROLL study)

in Gastrointestinal and Hepatic Pharmacology

Mohammad Shehab
Ahmad Alfadhli
Israa Abdullah
Wrood Alostad
Alaa Marei
Fatema Alrashed

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1388043

483 views

Editorial

Published on 09 Oct 2024

Editorial: Probiotics and their metabolites in cancer therapy

in Gastrointestinal and Hepatic Pharmacology

Pourya Gholizadeh
Amir Hossein Faghfouri
Pio Maria Furneri
Elnaz Faghfuri

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1497524

288 views

Systematic Review

Published on 08 Oct 2024

Worldwide research trends in Crohn’s disease treatment over the past 2 decades: a bibliometric analysis

in Gastrointestinal and Hepatic Pharmacology

Likang Xu
Jinzhao Zou
Chao Sun
Gong Chen
Sujun Gao

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1441785

782 views

Original Research

Published on 08 Oct 2024

Mouse liver sinusoidal endothelial cell responses to the glucocorticoid receptor agonist dexamethasone

in Gastrointestinal and Hepatic Pharmacology

Sabin Bhandari
Ingelin Kyrrestad
Jaione Simón-Santamaría
Ruomei Li
Karolina Joanna Szafranska
Gianina Dumitriu
Javier Sánchez Romano
Bård Smedsrød
Karen Kristine Sørensen

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1377136

657 views

Original Research

Published on 07 Oct 2024

Impact of albumin infusion on prognosis in ICU patients with cirrhosis and AKI: insights from the MIMIC-IV database

in Gastrointestinal and Hepatic Pharmacology

Mengqi Li
Yidi Ge
Jingjing Wang
Wenya Chen
Jiashuo Li
You Deng
Wen Xie

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1467752

697 views

Mini Review

Published on 30 Sep 2024

The role of autophagy in pancreatic diseases

in Gastrointestinal and Hepatic Pharmacology

Wen-Gang Zhang
Qing-Zhen Wu
Bo-Zong Shao

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1444657

447 views

Review

Published on 20 Sep 2024

Appraisal of postbiotics in cancer therapy

in Gastrointestinal and Hepatic Pharmacology

Aruna Senthil Kumar Sudaarsan
Asit Ranjan Ghosh

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1436021

767 views

Original Research

Published on 19 Sep 2024

Construction of an interpretable model for predicting survival outcomes in patients with middle to advanced hepatocellular carcinoma (≥5 cm) using lasso-cox regression

in Gastrointestinal and Hepatic Pharmacology

Han Li
Bo Yang
Chenjie Wang
Bo Li
Lei Han
Yi Jiang
Yanqiong Song
Lianbin Wen
Mingyue Rao
Jianwen Zhang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1452201

583 views

Original Research

Published on 18 Sep 2024

Emodin repairs interstitial cells of Cajal damaged by cholelithiasis in the gallbladder

in Gastrointestinal and Hepatic Pharmacology

Zhen-peng Huang
Hu Qiu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1424400

457 views

Original Research

Published on 18 Sep 2024

The novel TFEB agonist desloratadine ameliorates hepatic steatosis by activating the autophagy-lysosome pathway

in Gastrointestinal and Hepatic Pharmacology

Jieru Lin
Chunhuan Huang
Jingye Zhao
Lu Li
Zhenwei Wu
Tingyu Zhang
Yuyin Li
Wei Li
Baoqiang Guo
Zhenxing Liu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1449178

995 views

Original Research

Published on 12 Sep 2024

The real-world analysis of adverse events with teduglutide: a pharmacovigilance study based on the FAERS database

in Gastrointestinal and Hepatic Pharmacology

Xiaogan Wang
Hao Chen
Shuangshuang Han
Lingbo Li
Hongjin Chen
Bolin Yang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1404658

1,009 views

Original Research

Published on 10 Sep 2024

Combination of Youhua Kuijie Prescription and sulfasalazine can alleviate experimental colitis via IL-6/JAK2/STAT3 pathway

in Gastrointestinal and Hepatic Pharmacology

Lili Tang
Yuedong Liu
Hongwu Tao
Wenzhe Feng
Cong Ren
Yuping Shu
Ruijuan Luo
Xiangyi Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1437503

854 views

Navigation group

Articles

Alcohol-related Liver Disease (ALD): Current perspectives on pathogenesis, therapeutic strategies, and animal models

GYY4137, as a slow-releasing H2S donor, ameliorates sodium deoxycholate–induced chronic intestinal barrier injury and gut microbiota dysbiosis

Comparative effectiveness of treatments for recurrent Clostridioides difficile infection: a network meta-analysis of randomized controlled trials

Retinoid X receptor heterodimers in hepatic function: structural insights and therapeutic potential

Effectiveness of biologic therapies in achieving treatment targets in inflammatory bowel disease; real-world data from the Middle East (ENROLL study)

Editorial: Probiotics and their metabolites in cancer therapy

Worldwide research trends in Crohn’s disease treatment over the past 2 decades: a bibliometric analysis

Mouse liver sinusoidal endothelial cell responses to the glucocorticoid receptor agonist dexamethasone

Impact of albumin infusion on prognosis in ICU patients with cirrhosis and AKI: insights from the MIMIC-IV database

The role of autophagy in pancreatic diseases

Appraisal of postbiotics in cancer therapy

Construction of an interpretable model for predicting survival outcomes in patients with middle to advanced hepatocellular carcinoma (≥5 cm) using lasso-cox regression

Emodin repairs interstitial cells of Cajal damaged by cholelithiasis in the gallbladder

The novel TFEB agonist desloratadine ameliorates hepatic steatosis by activating the autophagy-lysosome pathway

The real-world analysis of adverse events with teduglutide: a pharmacovigilance study based on the FAERS database

Combination of Youhua Kuijie Prescription and sulfasalazine can alleviate experimental colitis via IL-6/JAK2/STAT3 pathway